<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2026"
  xmlns:ck0000883265="http://www.invesco.com/20260615"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0000883265-20260615.xsd" xlink:type="simple"/>
    <context id="C_20260615to20260615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2026-06-15</startDate>
            <endDate>2026-06-15</endDate>
        </period>
    </context>
    <context id="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0000883265:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-15</startDate>
            <endDate>2026-06-15</endDate>
        </period>
    </context>
    <context id="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265PreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0000883265:PreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-15</startDate>
            <endDate>2026-06-15</endDate>
        </period>
    </context>
    <context id="C_20260609to20260609_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0000883265:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-09</startDate>
            <endDate>2026-06-09</endDate>
        </period>
    </context>
    <context id="C_20260609to20260609_usgaapStatementClassOfStockAxis_ck0000883265PreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0000883265:PreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-09</startDate>
            <endDate>2026-06-09</endDate>
        </period>
    </context>
    <context id="C_20260609to20260609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2026-06-09</startDate>
            <endDate>2026-06-09</endDate>
        </period>
    </context>
    <context id="C_20160229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <instant>2016-02-29</instant>
        </period>
    </context>
    <context id="C_20170228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <instant>2017-02-28</instant>
        </period>
    </context>
    <context id="C_20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <instant>2018-02-28</instant>
        </period>
    </context>
    <context id="C_20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="C_20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="C_20160301to20170228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2016-03-01</startDate>
            <endDate>2017-02-28</endDate>
        </period>
    </context>
    <context id="C_20170301to20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2017-03-01</startDate>
            <endDate>2018-02-28</endDate>
        </period>
    </context>
    <context id="C_20180301to20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="C_20190301to20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="C_20200301to20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="C_20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="C_20260301to20260531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="C_20251201to20260228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="C_20250901to20251130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="C_20250601to20250831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="C_20250301to20250531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="C_20241201to20250228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="C_20240901to20241130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="C_20240601to20240831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="C_20240301to20240531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="C_20231201to20240229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="C_20260609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
        </entity>
        <period>
            <instant>2026-06-09</instant>
        </period>
    </context>
    <context id="C_20260615to20260615_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883265</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-15</startDate>
            <endDate>2026-06-15</endDate>
        </period>
    </context>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="SHARES">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Usd_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="C_20260615to20260615" id="F20260612054900492_0">0000883265</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="C_20260615to20260615" id="F20260612054900492_1">false</dei:AmendmentFlag>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104829481">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:DocumentType
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240729131433112">N-2</dei:DocumentType>
    <dei:EntityInvCompanyType
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104457236">N-2</dei:EntityInvCompanyType>
    <dei:DocumentRegistrationStatement
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104502991">true</dei:DocumentRegistrationStatement>
    <dei:InvestmentCompanyActRegistration
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104508368">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendment
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104518835">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:InvestmentCompanyRegistrationAmendmentNumber
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612134751303">5</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:EntityRegistrantName
      contextRef="C_20260615to20260615"
      id="Fxbrl_20250911121523822">INVESCO TRUST FOR INVESTMENT GRADE NEW YORK MUNICIPALS</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104532352">1331 Spring Street N.W</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104537800">Suite 2500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104542828">Atlanta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_20260615to20260615"
      id="Fxbrl_20250911121941741">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104553421">30309</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104558891">404</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104606113">892-0896</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="C_20260615to20260615_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240319104613216">Melanie Ringold, Esq.</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20260615to20260615_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240319104619096">11 Greenway Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_20260615to20260615_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240319104632176">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_20260615to20260615_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240319104637143">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20260615to20260615_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20240319104642363">77046</dei:EntityAddressPostalZipCode>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104650848">From time to time after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104655664">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104700127">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104705168">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104710592">false</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104715780">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104722032">false</dei:EffectiveWhenDeclaredSection8c>
    <dei:NewEffectiveDateForPreviousFiling
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104750308">false</dei:NewEffectiveDateForPreviousFiling>
    <dei:AdditionalSecurities462b
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104754684">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104801244">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104805343">false</dei:ExhibitsOnly462d>
    <cef:RegisteredClosedEndFundFlag
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104811104">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104815069">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104820263">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104824742">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20260615to20260615"
      id="Fxbrl_20250911121607093">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag
      contextRef="C_20260615to20260615"
      id="Fxbrl_20240319104839455">false</cef:NewCefOrBdcRegistrantFlag>
    <cef:ShareholderTransactionExpensesTableTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20250911101327791">


&lt;div&gt;


&lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left"&gt;Common Shareholder Transaction Expenses&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="padding-left:0.125in;width:87%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Maximum Sales Charge (&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as
        a percentage of offering price&lt;/span&gt;)&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;None&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align:super;width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="padding-left:0.125in;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Offering expenses borne by Common Shareholders (&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as
        a percentage of offering price&lt;/span&gt;)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="vertical-align:super;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="padding-left:0.125in;vertical-align:super;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Dividend Reinvestment Plan fees&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;None&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.25in"&gt;(1)&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;If Common Shares to which this Prospectus relates are sold to or through underwriters, the Prospectus Supplement
        will set forth any applicable sales charge and the estimated offering expenses borne by the Fund.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.25in"&gt;(2)&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;Common Shareholders will pay service fee of $2.50 and brokerage charges if they direct the Plan Agent to
        sell Common Shares held in a dividend reinvestment account. See &#x201c;Dividend Reinvestment Plan.&#x201d;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612121931290">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as
        a percentage of offering price&lt;/span&gt;</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="C_20260615to20260615"
      decimals="2"
      id="Fxbrl_20250911101706440"
      unitRef="Pure">0</cef:SalesLoadPercent>
    <cef:BasisOfTransactionFeesNoteTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612121946927">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as
        a percentage of offering price&lt;/span&gt;</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:OtherTransactionExpensesPercent
      contextRef="C_20260615to20260615"
      decimals="2"
      id="Fxbrl_20250911101757511"
      unitRef="Pure">0</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="C_20260615to20260615"
      decimals="0"
      id="Fxbrl_20250911101943998"
      unitRef="USD">0</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20250911101425754">


&lt;div&gt;


&lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="padding-bottom:1pt;white-space:nowrap;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;As
        a Percentage of Net Assets&lt;br/&gt;Attributable to Common Shares&lt;sup&gt;(3)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;white-space:nowrap;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left"&gt;Annual Expenses&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="width:87%;font:10pt Times New Roman, Times, Serif;padding-left:5.75pt"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Management
        fees&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.82&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:5.75pt"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Interest
        payments on borrowed funds&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1.74&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:5.75pt"&gt;Other expenses&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.13&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:5.75pt"&gt;Total annual expenses&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left;border-bottom:Black 2pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-top:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right;border-bottom:Black 2pt double"&gt;2.69&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.25in"&gt;(3)&lt;/td&gt;
    &lt;td&gt;Based upon average net assets applicable to Common Shares for the annual period ended February&#160;28, 2026.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.25in"&gt;(4)&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;The Fund pays the Adviser an annual fee, payable monthly, in an amount equal to 0.55% of the Fund&#x2019;s average
        daily Managed Assets. The fee shown above is based upon outstanding leverage of 31.67% of the Fund&#x2019;s total assets. If leverage of
        more than 31.67% of the Fund&#x2019;s total assets is used, the management fees shown would be higher.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.25in"&gt;(5)&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;Based upon the Fund&#x2019;s outstanding borrowings as of February&#160;28, 2026 of approximately $29,945,000,
        and outstanding preferred shares as of February&#160;28, 2026 of approximately 46,400,000, and the average daily weighted interest rate
        for the period ended February&#160;28, 2026 of 3.11%,
        and dividends on preferred shares at an annual rate of 3.73%.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20250911102016265"
      unitRef="Pure">0.0082</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20250911102110609"
      unitRef="Pure">0.0174</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20250911102201673"
      unitRef="Pure">0.0013</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20250911102338481"
      unitRef="Pure">0.0269</cef:TotalAnnualExpensesPercent>
    <cef:AnnualInterestRatePercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20260612122045347"
      unitRef="Pure">0.0311</cef:AnnualInterestRatePercent>
    <cef:PurposeOfFeeTableNoteTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612122116591">


&lt;div style="font-size:10pt;font-family:Times New Roman"&gt;


&lt;p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0pt"&gt;The purpose of the table and the example below
is to help you understand the fees and expenses that you, as a holder of Common Shares, would bear directly or indirectly.&lt;/p&gt; &lt;/div&gt;
</cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612122150776">


&lt;div style="font-size:10pt;font-family:Times New Roman"&gt;


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Example&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0pt"&gt;The following example illustrates the expenses
that you would pay on a $1,000 investment in Common Shares, assuming (1)&#160;&#x201c;Total annual expenses&#x201d; of x.xx% of net assets
attributable to Common Shares and (2)&#160;a 5% annual return*:&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;text-align:center;font:10pt Times New Roman, Times, Serif"&gt;1 Year&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;text-align:center;font:10pt Times New Roman, Times, Serif"&gt;3 Years&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;text-align:center;font:10pt Times New Roman, Times, Serif"&gt;5 Years&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;text-align:center;font:10pt Times New Roman, Times, Serif"&gt;10 Years&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;Total
        Expenses paid by Common Shareholders&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;27&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;84&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;142&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;302&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;* The Example should not be considered a representation
of future expenses or returns. Actual expenses may be higher or lower than those assumed. Moreover, the Fund&#x2019;s actual rate of return
may be higher or lower than the hypothetical 5% return shown in the example&lt;/strong&gt;. The example assumes that all dividends and distributions
are reinvested at net asset value.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.25in"&gt;(1)&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;The example above does not include sales charges or estimated offering costs. In connection with an offering
        of Common Shares, the Prospectus Supplement will set forth an Example including sales charge and estimated offering costs.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="C_20260615to20260615"
      decimals="0"
      id="Fxbrl_20250911102706139"
      unitRef="USD">27</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="C_20260615to20260615"
      decimals="0"
      id="Fxbrl_20250911102735890"
      unitRef="USD">84</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="C_20260615to20260615"
      decimals="0"
      id="Fxbrl_20250911133228998"
      unitRef="USD">142</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="C_20260615to20260615"
      decimals="0"
      id="Fxbrl_20250911133232245"
      unitRef="USD">302</cef:ExpenseExampleYears1to10>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20200229"
      decimals="2"
      id="Fxbrl_20250911161857347"
      unitRef="Usd_per_Share">15.03</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20190228"
      decimals="2"
      id="Fxbrl_20250911161901691"
      unitRef="Usd_per_Share">13.9</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20180228"
      decimals="2"
      id="Fxbrl_20250911161903427"
      unitRef="Usd_per_Share">14.15</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20170228"
      decimals="2"
      id="Fxbrl_20250911161905058"
      unitRef="Usd_per_Share">14.4</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20160229"
      decimals="2"
      id="Fxbrl_20250911161906698"
      unitRef="Usd_per_Share">15.29</us-gaap:NetAssetValuePerShare>
    <cef:AnnualDividendPayment
      contextRef="C_20200301to20210228"
      decimals="2"
      id="Fxbrl_20250911162333298_xbrl_20250911161920858"
      unitRef="Usd_per_Share">-0.55</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20190301to20200229"
      decimals="2"
      id="Fxbrl_20250911162333298_xbrl_20250911161922482"
      unitRef="Usd_per_Share">-0.6</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20180301to20190228"
      decimals="2"
      id="Fxbrl_20250911162333298_xbrl_20250911161925986"
      unitRef="Usd_per_Share">-0.68</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20170301to20180228"
      decimals="2"
      id="Fxbrl_20250911162333298_xbrl_20250911161927890"
      unitRef="Usd_per_Share">-0.69</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20160301to20170228"
      decimals="2"
      id="Fxbrl_20250911162333298_xbrl_20250911161929690"
      unitRef="Usd_per_Share">-0.77</cef:AnnualDividendPayment>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20210228"
      decimals="2"
      id="Fxbrl_20250911161920858"
      unitRef="Usd_per_Share">14.22</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20200229"
      decimals="2"
      id="Fxbrl_20250911161922482"
      unitRef="Usd_per_Share">15.03</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20190228"
      decimals="2"
      id="Fxbrl_20250911161925986"
      unitRef="Usd_per_Share">13.9</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20180228"
      decimals="2"
      id="Fxbrl_20250911161927890"
      unitRef="Usd_per_Share">14.15</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20170228"
      decimals="2"
      id="Fxbrl_20250911161929690"
      unitRef="Usd_per_Share">14.4</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="C_20210228"
      decimals="2"
      id="Fxbrl_20250911162343107_xbrl_20250911161920858"
      unitRef="Usd_per_Share">13</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20200229"
      decimals="2"
      id="Fxbrl_20250911162343107_xbrl_20250911161922482"
      unitRef="Usd_per_Share">13.58</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20190228"
      decimals="2"
      id="Fxbrl_20250911162343107_xbrl_20250911161925986"
      unitRef="Usd_per_Share">12.96</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20180228"
      decimals="2"
      id="Fxbrl_20250911162343107_xbrl_20250911161927890"
      unitRef="Usd_per_Share">13.06</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20170228"
      decimals="2"
      id="Fxbrl_20250911162343107_xbrl_20250911161929690"
      unitRef="Usd_per_Share">13.48</us-gaap:SharePrice>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20210228"
      decimals="-3"
      id="Fxbrl_20250911162845554_xbrl_20250911162343107_xbrl_20250911161920858"
      unitRef="USD">90400000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20200229"
      decimals="-3"
      id="Fxbrl_20250911162845554_xbrl_20250911162343107_xbrl_20250911161922482"
      unitRef="USD">90400000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20190228"
      decimals="-3"
      id="Fxbrl_20250911162845554_xbrl_20250911162343107_xbrl_20250911161925986"
      unitRef="USD">90400000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20180228"
      decimals="-3"
      id="Fxbrl_20250911162845554_xbrl_20250911162343107_xbrl_20250911161927890"
      unitRef="USD">90400000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20170228"
      decimals="-3"
      id="Fxbrl_20250911162845554_xbrl_20250911162343107_xbrl_20250911161929690"
      unitRef="USD">90400000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20210228"
      decimals="0"
      id="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161920858"
      unitRef="Usd_per_Share">406330</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20200229"
      decimals="0"
      id="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161922482"
      unitRef="Usd_per_Share">423912</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20190228"
      decimals="0"
      id="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161925986"
      unitRef="Usd_per_Share">399509</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20180228"
      decimals="0"
      id="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161927890"
      unitRef="Usd_per_Share">404801</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20170228"
      decimals="0"
      id="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161929690"
      unitRef="Usd_per_Share">410327</cef:SeniorSecuritiesCvgPerUnit>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="C_20210228"
      decimals="0"
      id="Fxbrl_20250911162854266_xbrl_20250911162333298_xbrl_20250911161920858"
      unitRef="Usd_per_Share">100000</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="C_20200229"
      decimals="0"
      id="Fxbrl_20250911162854266_xbrl_20250911162333298_xbrl_20250911161922482"
      unitRef="Usd_per_Share">100000</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="C_20190228"
      decimals="0"
      id="Fxbrl_20250911162854266_xbrl_20250911162333298_xbrl_20250911161925986"
      unitRef="Usd_per_Share">100000</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="C_20180228"
      decimals="0"
      id="Fxbrl_20250911162854266_xbrl_20250911162333298_xbrl_20250911161927890"
      unitRef="Usd_per_Share">100000</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="C_20170228"
      decimals="0"
      id="Fxbrl_20250911162854266_xbrl_20250911162333298_xbrl_20250911161929690"
      unitRef="Usd_per_Share">100000</us-gaap:PreferredStockLiquidationPreference>
    <cef:SeniorSecuritiesNoteTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20250911163756196">


&lt;div&gt;


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="a_004"&gt;&lt;strong&gt;SENIOR SECURITIES&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The information regarding the Fund&#x2019;s
outstanding senior securities at the end of each of the Fund&#x2019;s last five fiscal years are included in the Fund&#x2019;s financial
highlights, which are incorporated by reference from the Fund&#x2019;s &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/883265/000119312526210646/d122322dncsr.htm"&gt;Annual
Report&lt;/a&gt; for the fiscal year ended February&#160;28, 2026 (File No.&#160;811-06537), as filed with the SEC on Form&#160;N-CSR on May&#160;7,
2026. The information regarding the Fund's outstanding senior securities for the fiscal years ended February&#160;28, 2021, February&#160;29,
2020, February&#160;28, 2019, February&#160;28, 2018, and February&#160;28, 2017 is set forth in the table above. See &#x201c;Financial
Highlights&#x201d; above.&lt;/p&gt; &lt;/div&gt; </cef:SeniorSecuritiesNoteTextBlock>
    <cef:SharePriceTableTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20250911105007580">


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The following table sets forth, for
each of the periods indicated: (i)&#160;the high and low closing market prices for the Common Shares reported as of the end of the day
on the NYSE, (ii)&#160;the high and low net asset value (NAV) of the Common Shares, and (iii)&#160;the high and low of the premium or
discount to NAV (expressed as a percentage) of shares of the Common Shares. Net asset value is generally determined on each day that the
NYSE is open for business. See &#x201c;Net Asset Value&#x201d; for information as to the determination of the Fund&#x2019;s NAV.&lt;/p&gt; &lt;/div&gt;



&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;Market Price&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:1pt solid black;font-size:10pt;font-weight:bold;text-align:center"&gt;NAV&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align:super;border-bottom:Black 1pt solid;text-align:center;font-size:10pt;font-weight:bold"&gt;Premium/(Discount)
        to NAV&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="border-bottom:Black 1pt solid;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;During Quarter Ended&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="width:22%;font:10pt Times New Roman, Times, Serif"&gt;May&#160;2026&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.58&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.57&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.15&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.53&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;6.08&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.19&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;February&#160;2026&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.07&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.40&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.15&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.83&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.29&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;3.73&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;November&#160;2025&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.49&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.09&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.16&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.32&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4.08&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(3.58&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;August&#160;2025&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.56&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.98&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.67&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.21&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.97&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(5.67&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;May&#160;2025&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.75&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.71&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.67&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.29&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(2.82&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.57&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;February&#160;2025&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.66&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.16&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.04&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.36&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(3.16&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(10.56&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;November&#160;2024&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.62&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.08&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.21&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.61&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(3.42&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(6.32&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;August&#160;2024&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.42&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.84&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.27&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.70&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(5.23&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(8.96&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;May&#160;2024&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.07&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.34&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.20&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.67&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(6.11&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(13.04&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;February&#160;2024&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.66&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.12&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12.25&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;11.81&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(11.69&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(15.54&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin:0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top;text-align:justify"&gt;
    &lt;td style="vertical-align:super;width:0.25in;text-align:left"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;Based on the Fund&#x2019;s computations.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.25in"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&#160;&lt;/td&gt;
    &lt;td&gt;Calculated based on the information presented. Percentages are rounded.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="C_20260301to20260531"
      decimals="2"
      id="Fxbrl_20260612022236487_xbrl_20250911110332499"
      unitRef="Usd_per_Share">11.58</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20260301to20260531"
      decimals="2"
      id="Fxbrl_20260612022236487_xbrl_20250911110342556"
      unitRef="Usd_per_Share">10.57</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20260301to20260531"
      decimals="2"
      id="Fxbrl_20260612022236487_xbrl_20250911112156844"
      unitRef="Usd_per_Share">11.15</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20260301to20260531"
      decimals="2"
      id="Fxbrl_20260612022236487_xbrl_20250911112216274"
      unitRef="Usd_per_Share">10.53</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20260301to20260531"
      decimals="4"
      id="Fxbrl_20260612022236487_xbrl_20250911112234615"
      unitRef="Pure">0.0608</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20260301to20260531"
      decimals="4"
      id="Fxbrl_20260612022236487_xbrl_20250911112302270"
      unitRef="Pure">0.0019</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20251201to20260228"
      decimals="2"
      id="Fxbrl_20260612022235119_xbrl_20250911110332499"
      unitRef="Usd_per_Share">12.07</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20251201to20260228"
      decimals="2"
      id="Fxbrl_20260612022235119_xbrl_20250911110342556"
      unitRef="Usd_per_Share">11.4</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20251201to20260228"
      decimals="2"
      id="Fxbrl_20260612022235119_xbrl_20250911112156844"
      unitRef="Usd_per_Share">11.15</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20251201to20260228"
      decimals="2"
      id="Fxbrl_20260612022235119_xbrl_20250911112216274"
      unitRef="Usd_per_Share">10.83</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20251201to20260228"
      decimals="4"
      id="Fxbrl_20260612022235119_xbrl_20250911112234615"
      unitRef="Pure">0.0929</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20251201to20260228"
      decimals="4"
      id="Fxbrl_20260612022235119_xbrl_20250911112302270"
      unitRef="Pure">0.0373</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20250901to20251130"
      decimals="2"
      id="Fxbrl_20260612022233881_xbrl_20250911110332499"
      unitRef="Usd_per_Share">11.49</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20250901to20251130"
      decimals="2"
      id="Fxbrl_20260612022233881_xbrl_20250911110342556"
      unitRef="Usd_per_Share">10.09</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20250901to20251130"
      decimals="2"
      id="Fxbrl_20260612022233881_xbrl_20250911112156844"
      unitRef="Usd_per_Share">11.16</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20250901to20251130"
      decimals="2"
      id="Fxbrl_20260612022233881_xbrl_20250911112216274"
      unitRef="Usd_per_Share">10.32</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250901to20251130"
      decimals="4"
      id="Fxbrl_20260612022233881_xbrl_20250911112234615"
      unitRef="Pure">0.0408</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250901to20251130"
      decimals="4"
      id="Fxbrl_20260612022233881_xbrl_20250911112302270"
      unitRef="Pure">-0.0358</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20250601to20250831"
      decimals="2"
      id="Fxbrl_20250911110332499"
      unitRef="Usd_per_Share">10.56</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20250601to20250831"
      decimals="2"
      id="Fxbrl_20250911110342556"
      unitRef="Usd_per_Share">9.98</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20250601to20250831"
      decimals="2"
      id="Fxbrl_20250911112156844"
      unitRef="Usd_per_Share">10.67</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20250601to20250831"
      decimals="2"
      id="Fxbrl_20250911112216274"
      unitRef="Usd_per_Share">10.21</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250601to20250831"
      decimals="4"
      id="Fxbrl_20250911112234615"
      unitRef="Pure">0.0097</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250601to20250831"
      decimals="4"
      id="Fxbrl_20250911112302270"
      unitRef="Pure">-0.0567</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20250301to20250531"
      decimals="2"
      id="Fxbrl_20250911112452223_xbrl_20250911110332499"
      unitRef="Usd_per_Share">10.75</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20250301to20250531"
      decimals="2"
      id="Fxbrl_20250911112452223_xbrl_20250911110342556"
      unitRef="Usd_per_Share">9.71</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20250301to20250531"
      decimals="2"
      id="Fxbrl_20250911112452223_xbrl_20250911112156844"
      unitRef="Usd_per_Share">11.67</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20250301to20250531"
      decimals="2"
      id="Fxbrl_20250911112452223_xbrl_20250911112216274"
      unitRef="Usd_per_Share">10.29</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250301to20250531"
      decimals="4"
      id="Fxbrl_20250911112452223_xbrl_20250911112234615"
      unitRef="Pure">-0.0282</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250301to20250531"
      decimals="4"
      id="Fxbrl_20250911112452223_xbrl_20250911112302270"
      unitRef="Pure">-0.0957</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20241201to20250228"
      decimals="2"
      id="Fxbrl_20250911112453826_xbrl_20250911110332499"
      unitRef="Usd_per_Share">11.66</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20241201to20250228"
      decimals="2"
      id="Fxbrl_20250911112453826_xbrl_20250911110342556"
      unitRef="Usd_per_Share">10.16</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20241201to20250228"
      decimals="2"
      id="Fxbrl_20250911112453826_xbrl_20250911112156844"
      unitRef="Usd_per_Share">12.04</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20241201to20250228"
      decimals="2"
      id="Fxbrl_20250911112453826_xbrl_20250911112216274"
      unitRef="Usd_per_Share">11.36</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20241201to20250228"
      decimals="4"
      id="Fxbrl_20250911112453826_xbrl_20250911112234615"
      unitRef="Pure">-0.0316</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20241201to20250228"
      decimals="4"
      id="Fxbrl_20250911112453826_xbrl_20250911112302270"
      unitRef="Pure">-0.1056</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20240901to20241130"
      decimals="2"
      id="Fxbrl_20250911112455356_xbrl_20250911110332499"
      unitRef="Usd_per_Share">11.62</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240901to20241130"
      decimals="2"
      id="Fxbrl_20250911112455356_xbrl_20250911110342556"
      unitRef="Usd_per_Share">11.08</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20240901to20241130"
      decimals="2"
      id="Fxbrl_20250911112455356_xbrl_20250911112156844"
      unitRef="Usd_per_Share">12.21</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20240901to20241130"
      decimals="2"
      id="Fxbrl_20250911112455356_xbrl_20250911112216274"
      unitRef="Usd_per_Share">11.61</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240901to20241130"
      decimals="4"
      id="Fxbrl_20250911112455356_xbrl_20250911112234615"
      unitRef="Pure">-0.0342</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240901to20241130"
      decimals="4"
      id="Fxbrl_20250911112455356_xbrl_20250911112302270"
      unitRef="Pure">-0.0632</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20240601to20240831"
      decimals="2"
      id="Fxbrl_20250911112457369_xbrl_20250911110332499"
      unitRef="Usd_per_Share">11.42</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240601to20240831"
      decimals="2"
      id="Fxbrl_20250911112457369_xbrl_20250911110342556"
      unitRef="Usd_per_Share">10.84</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20240601to20240831"
      decimals="2"
      id="Fxbrl_20250911112457369_xbrl_20250911112156844"
      unitRef="Usd_per_Share">12.27</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20240601to20240831"
      decimals="2"
      id="Fxbrl_20250911112457369_xbrl_20250911112216274"
      unitRef="Usd_per_Share">11.7</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240601to20240831"
      decimals="4"
      id="Fxbrl_20250911112457369_xbrl_20250911112234615"
      unitRef="Pure">-0.0523</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240601to20240831"
      decimals="4"
      id="Fxbrl_20250911112457369_xbrl_20250911112302270"
      unitRef="Pure">-0.0896</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20240301to20240531"
      decimals="2"
      id="Fxbrl_20250911112459390_xbrl_20250911110332499"
      unitRef="Usd_per_Share">11.07</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240301to20240531"
      decimals="2"
      id="Fxbrl_20250911112459390_xbrl_20250911110342556"
      unitRef="Usd_per_Share">10.34</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20240301to20240531"
      decimals="2"
      id="Fxbrl_20250911112459390_xbrl_20250911112156844"
      unitRef="Usd_per_Share">12.2</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20240301to20240531"
      decimals="2"
      id="Fxbrl_20250911112459390_xbrl_20250911112216274"
      unitRef="Usd_per_Share">11.67</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240301to20240531"
      decimals="4"
      id="Fxbrl_20250911112459390_xbrl_20250911112234615"
      unitRef="Pure">-0.0611</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240301to20240531"
      decimals="4"
      id="Fxbrl_20250911112459390_xbrl_20250911112302270"
      unitRef="Pure">-0.1304</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20231201to20240229"
      decimals="2"
      id="Fxbrl_20250911112501141_xbrl_20250911110332499"
      unitRef="Usd_per_Share">10.66</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20231201to20240229"
      decimals="2"
      id="Fxbrl_20250911112501141_xbrl_20250911110342556"
      unitRef="Usd_per_Share">10.12</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20231201to20240229"
      decimals="2"
      id="Fxbrl_20250911112501141_xbrl_20250911112156844"
      unitRef="Usd_per_Share">12.25</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20231201to20240229"
      decimals="2"
      id="Fxbrl_20250911112501141_xbrl_20250911112216274"
      unitRef="Usd_per_Share">11.81</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231201to20240229"
      decimals="4"
      id="Fxbrl_20250911112501141_xbrl_20250911112234615"
      unitRef="Pure">-0.1169</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231201to20240229"
      decimals="4"
      id="Fxbrl_20250911112501141_xbrl_20250911112302270"
      unitRef="Pure">-0.1554</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20260609"
      decimals="2"
      id="Fxbrl_20260612022909022"
      unitRef="Usd_per_Share">10.91</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="C_20260609"
      decimals="2"
      id="Fxbrl_20260612022945376"
      unitRef="Usd_per_Share">11.2</us-gaap:SharePrice>
    <cef:InvestmentObjectivesAndPracticesTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612115720328">


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="a_008"&gt;&lt;strong&gt;INVESTMENT OBJECTIVE AND POLICIES&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;Investment Objective and Policies&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Please refer to the section of the
Fund&#x2019;s most recent &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/883265/000119312526210646/d122322dncsr.htm"&gt;annual report&lt;/a&gt;
on Form&#160;N-CSR, entitled &#x201c;Additional Information-Investment Objective, Policies and Principal Risks of the Trust-Investment
Objective&#x201d; and &#x201c;-Investment Policies of the Trust,&#x201d; as such investment objective and policies may be supplemented from
time to time, which is incorporated by reference herein, for a discussion of the Fund&#x2019;s investment objective and policies.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;Portfolio Turnover&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund will buy and sell securities
to seek to accomplish its investment objective. Portfolio turnover generally involves some expense to the Fund, including brokerage commissions
or dealer mark-ups and other transaction costs on the sale of securities and reinvestment in other securities. The Fund&#x2019;s portfolio
turnover rate may vary greatly from year to year. For the past two fiscal years, the Fund&#x2019;s portfolio turnover rate was as follows.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif"&gt;Fiscal Year Ended&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align:center;font:10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;Portfolio Turnover Rate&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;width:49%;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;February
        28, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:47%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;21&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;February
        28, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;16&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0pt"&gt;&lt;strong&gt;Investment Restrictions&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund has adopted certain other
investment limitations designed to limit investment risk. These limitations are fundamental and may not be changed without the approval
of the holders of a majority of the outstanding Common Shares, as defined in the 1940 Act (and preferred shares, if any, voting together
as a single class), which is defined by the 1940 Act as the lesser of (i)&#160;67% or more of the Fund&#x2019;s voting securities present
at a meeting, if the holders of more than 50% of the Fund&#x2019;s outstanding voting securities are present or represented by proxy; or
(ii)&#160;more than 50% of the Fund&#x2019;s outstanding voting securities. See &#x201c;Investment Restrictions&#x201d; in the SAI for a
complete list of the fundamental investment policies of the Fund.&lt;/p&gt; &lt;/div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="a_009"&gt;&lt;strong&gt;USE OF LEVERAGE&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund uses leverage to pursue
its investment objective. The Fund may use leverage to the extent permitted by the 1940 Act. The Fund may source leverage through a number
of methods, including through issuing preferred shares. In addition, the Fund may also use other forms of leverage including, but not
limited to certain derivatives that have the economic effect of leverage. In addition, the Fund may also use other forms of leverage including,
but not limited to, portfolio investments that have the economic effect of leverage, such as by investing in residual interest certificates
of tender option bond trusts, also called inverse floating rate securities. The Fund may reduce or increase leverage based upon changes
in market conditions and anticipates that its leverage ratio will vary from time to time based upon variations in the value of the Fund&#x2019;s
holdings.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Currently, the Fund employs leverage
through its outstanding series of variable rate muni term preferred shares (&#x201c;Preferred Shares&#x201d;), which have seniority over
the Common Shares. The Fund currently also invests in residual interest certificates of tender option bond trusts, also called inverse
floating rate securities, that have the economic effect of leverage because the Fund&#x2019;s investment exposure to the underlying bonds
held by the trust have been effectively financed by the trust&#x2019;s issuance of floating rate certificates.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The amounts and forms of leverage
used by the Fund may vary with prevailing market or economic conditions. The timing and terms of any leverage transactions are determined
by the Board of Trustees. There is no assurance that the Fund&#x2019;s leveraging strategy will be successful.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may use derivative instruments,
including futures, for a variety of purposes, including hedging, risk management, portfolio management or to earn income.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;So long as the net rate of income
received from the Fund&#x2019;s investments purchased with leverage proceeds exceeds the then current interest rate on such leverage, the
investment of the proceeds of leverage will generate more net income than if the Fund had not leveraged itself. However, if the rate of
net income received from the Fund&#x2019;s portfolio investments purchased with the proceeds of leverage is less than the then current
interest rate on that leverage, the Fund may be required to utilize other Fund assets to make interest payments on its leveraging instruments.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund pays a management fee to
the Adviser (which in turn may pay a portion of such fee to any Sub-Adviser utilized) based on a percentage of Managed Assets. Managed
Assets include the proceeds realized and managed from the Fund&#x2019;s use of leverage (excluding the leverage exposure attributable to
the use of futures, options and similar derivatives). Because Managed Assets includes the Fund&#x2019;s net assets as well as assets that
are attributable to the Fund&#x2019;s investment of the proceeds of its leverage, it is anticipated that the Fund&#x2019;s Managed Assets
will be greater than its net assets. The Adviser will be responsible for using leverage to pursue the Fund&#x2019;s investment objective.
The Adviser will base its decision regarding whether and how much leverage to use for the Fund, and the terms of that leverage, on its
assessment of whether such use of leverage is in the best interests of the Fund. However, a decision to employ or increase leverage will
have the effect, all other things being equal, of increasing Managed Assets and in turn the Adviser&#x2019;s and any Sub-Adviser&#x2019;s
management fees. Thus, the Adviser may have a conflict of interest in determining whether to use or increase leverage. The Adviser will
seek to manage that potential conflict by recommending to the Fund&#x2019;s Board of Trustees to leverage the Fund (or increase such leverage)
only when it determines that such action would be in the best interests of the Fund and its Shareholders, and by periodically reviewing
with the Board of Trustees the Fund&#x2019;s performance and the impact of the use of leverage on that performance.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Under the 1940 Act, the Fund is not
permitted to issue &#x201c;senior securities&#x201d; that are preferred shares if, immediately after the issuance of preferred shares, the
asset coverage ratio with respect to such preferred shares would be less than 200%. With respect to any such preferred shares, asset coverage
means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by senior securities,
bears to the aggregate amount of senior securities representing indebtedness of the Fund plus the aggregate liquidation preference of
such preferred shares.&lt;/p&gt; &lt;/div&gt;  &lt;/div&gt; 


&lt;div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Preferred Shares&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may authorize and issue
preferred shares with rights as determined by the Board of Trustees, by action of the Board of Trustees without prior approval of the
holders of the Common Shares. Common Shareholders have no preemptive right to purchase any preferred shares that might be issued. Any
such preferred share offering would be subject to the limits imposed by the 1940 Act. Under the 1940 Act, the Fund may not issue preferred
shares if, immediately after issuance, the Fund would have asset coverage (as defined in the 1940 Act) of less than 200% (i.e., for every
dollar of preferred shares outstanding, the Fund is required to have at least two dollars of assets).&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The terms of the preferred shares,
including their distribution rate, voting rights, liquidation preference and redemption provisions, will be determined by the Board (subject
to applicable law and the Fund&#x2019;s Declaration of Trust) if and when it authorizes the preferred shares. The Fund may issue preferred
shares that provide for the periodic redetermination of the distribution rate at relatively short intervals through an auction or remarketing
procedure, although the terms of the preferred shares may also enable the Fund to lengthen such intervals. At times, the distribution
rate on the Fund&#x2019;s preferred shares may exceed the Fund&#x2019;s return after expenses on the investment of proceeds from the preferred
shares, resulting in a lower rate of return to Common Shareholders than if the preferred shares were not outstanding.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;i&gt;Preferred Shares. &lt;/i&gt;On May&#160;9,
2012, the Fund issued 464 Series&#160;2015/6-VTN VMTP Shares (the &#x201c;Preferred Shares&#x201d;), with a liquidation preference of $100,000
per share, pursuant to an offering exempt from registration under the Securities Act of 1933, as amended (the &#x201c;1933 Act&#x201d;).
The Preferred Shares are a variable rate form of preferred shares with a mandatory redemption date and are considered debt for financial
reporting purposes. Effective December&#160;1, 2023, the Fund extended the term of the Preferred Shares and is required to redeem all
outstanding Preferred Shares on June&#160;4, 2029, unless earlier redeemed, repurchased or extended. The Preferred Shares are subject
to optional and mandatory redemption in certain circumstances. The redemption price per share is equal to the sum of the liquidation preference
per share plus any accumulated but unpaid dividends and a redemption premium, if any. Starting six months prior to the term redemption
date, the Fund will be required to earmark assets having a value equal to 110% of the redemption amount.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;As of February&#160;28, 2026, the
Fund had outstanding preferred shares with an aggregate liquidation preference of $46,400,000, representing approximately 3.73% of the
Fund&#x2019;s total assets as of such date.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Effects of Leverage&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Assuming (i)&#160;the use by the
Fund of leverage representing approximately 31.67% of the Fund&#x2019;s total assets (including the proceeds of such leverage), 12.42%
of the Fund&#x2019;s total assets being attributable to borrowings and 19.25% of the Fund&#x2019;s total assets being attributable to preferred
shares, and (ii)&#160;interest costs to the Fund at an average annual rate of 3.11%
with respect to borrowings and dividends on preferred shares at an annual rate of 3.73%, then the incremental income generated by the
Fund&#x2019;s portfolio (net of estimated expenses related to the leverage) must exceed approximately 5.69% to cover such interest expense.
Of course, these numbers are merely estimates used for illustration. The amount of leverage used by the Fund as well as actual interest
expenses and dividend payments on such leverage may vary frequently and may be significantly higher or lower than the rate estimated above.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;The
following table is furnished pursuant to requirements of the SEC. It is designed to illustrate the effect of leverage on Common Share
total return, assuming investment portfolio total returns (comprised of income, net expenses and changes in the value of investments held
in the Fund&#x2019;s portfolio) of -10%, -5%, 0%, 5% and 10%. These assumed investment portfolio returns are hypothetical figures and are
not necessarily indicative of what the Fund&#x2019;s investment portfolio returns will be. The table further reflects the issuance of leverage
representing approximately 31.67% of the Fund&#x2019;s total assets (including the proceeds of such leverage), and the Fund&#x2019;s currently
projected annual interest rate of 3.11%
with respect to borrowings and projected annual dividends on preferred shares of 3.73%. The table does not reflect any offering costs
of Common Shares or leverage.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt; 


&lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="width:35%;font:bold 10pt Times New Roman, Times, Serif;text-align:left"&gt;Assumed portfolio total return (net of expenses)&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(10.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(5.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt"&gt;Common Share total return&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(13.14&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(7.29&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(1.44&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4.40&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.25&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt;  &lt;/div&gt; 


&lt;div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Common Share total return is composed of two elements&#x2014;the
Common Share dividends paid by the Fund (the amount of which is largely determined by the Fund&#x2019;s net investment income after paying
the carrying cost of leverage) and realized and unrealized gains or losses on the value of the securities the Fund owns. As required by
SEC rules, the table assumes that the Fund is more likely to suffer capital loss than to enjoy capital appreciation. For example, to assume
a total return of 0%, the Fund must assume that the net investment income it receives on its investments is entirely offset by losses
on the value of those investments. This table reflects the hypothetical performance of the Fund&#x2019;s portfolio and not the performance
of the Fund&#x2019;s Common Shares, the value of which will be determined by market and other factors.&lt;/p&gt; &lt;/div&gt;  &lt;/div&gt;
</cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:EffectsOfLeverageTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612115854323">


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="a_009"&gt;&lt;strong&gt;USE OF LEVERAGE&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund uses leverage to pursue
its investment objective. The Fund may use leverage to the extent permitted by the 1940 Act. The Fund may source leverage through a number
of methods, including through issuing preferred shares. In addition, the Fund may also use other forms of leverage including, but not
limited to certain derivatives that have the economic effect of leverage. In addition, the Fund may also use other forms of leverage including,
but not limited to, portfolio investments that have the economic effect of leverage, such as by investing in residual interest certificates
of tender option bond trusts, also called inverse floating rate securities. The Fund may reduce or increase leverage based upon changes
in market conditions and anticipates that its leverage ratio will vary from time to time based upon variations in the value of the Fund&#x2019;s
holdings.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Currently, the Fund employs leverage
through its outstanding series of variable rate muni term preferred shares (&#x201c;Preferred Shares&#x201d;), which have seniority over
the Common Shares. The Fund currently also invests in residual interest certificates of tender option bond trusts, also called inverse
floating rate securities, that have the economic effect of leverage because the Fund&#x2019;s investment exposure to the underlying bonds
held by the trust have been effectively financed by the trust&#x2019;s issuance of floating rate certificates.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The amounts and forms of leverage
used by the Fund may vary with prevailing market or economic conditions. The timing and terms of any leverage transactions are determined
by the Board of Trustees. There is no assurance that the Fund&#x2019;s leveraging strategy will be successful.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may use derivative instruments,
including futures, for a variety of purposes, including hedging, risk management, portfolio management or to earn income.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;So long as the net rate of income
received from the Fund&#x2019;s investments purchased with leverage proceeds exceeds the then current interest rate on such leverage, the
investment of the proceeds of leverage will generate more net income than if the Fund had not leveraged itself. However, if the rate of
net income received from the Fund&#x2019;s portfolio investments purchased with the proceeds of leverage is less than the then current
interest rate on that leverage, the Fund may be required to utilize other Fund assets to make interest payments on its leveraging instruments.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund pays a management fee to
the Adviser (which in turn may pay a portion of such fee to any Sub-Adviser utilized) based on a percentage of Managed Assets. Managed
Assets include the proceeds realized and managed from the Fund&#x2019;s use of leverage (excluding the leverage exposure attributable to
the use of futures, options and similar derivatives). Because Managed Assets includes the Fund&#x2019;s net assets as well as assets that
are attributable to the Fund&#x2019;s investment of the proceeds of its leverage, it is anticipated that the Fund&#x2019;s Managed Assets
will be greater than its net assets. The Adviser will be responsible for using leverage to pursue the Fund&#x2019;s investment objective.
The Adviser will base its decision regarding whether and how much leverage to use for the Fund, and the terms of that leverage, on its
assessment of whether such use of leverage is in the best interests of the Fund. However, a decision to employ or increase leverage will
have the effect, all other things being equal, of increasing Managed Assets and in turn the Adviser&#x2019;s and any Sub-Adviser&#x2019;s
management fees. Thus, the Adviser may have a conflict of interest in determining whether to use or increase leverage. The Adviser will
seek to manage that potential conflict by recommending to the Fund&#x2019;s Board of Trustees to leverage the Fund (or increase such leverage)
only when it determines that such action would be in the best interests of the Fund and its Shareholders, and by periodically reviewing
with the Board of Trustees the Fund&#x2019;s performance and the impact of the use of leverage on that performance.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Under the 1940 Act, the Fund is not
permitted to issue &#x201c;senior securities&#x201d; that are preferred shares if, immediately after the issuance of preferred shares, the
asset coverage ratio with respect to such preferred shares would be less than 200%. With respect to any such preferred shares, asset coverage
means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by senior securities,
bears to the aggregate amount of senior securities representing indebtedness of the Fund plus the aggregate liquidation preference of
such preferred shares.&lt;/p&gt; &lt;/div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Preferred Shares&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may authorize and issue
preferred shares with rights as determined by the Board of Trustees, by action of the Board of Trustees without prior approval of the
holders of the Common Shares. Common Shareholders have no preemptive right to purchase any preferred shares that might be issued. Any
such preferred share offering would be subject to the limits imposed by the 1940 Act. Under the 1940 Act, the Fund may not issue preferred
shares if, immediately after issuance, the Fund would have asset coverage (as defined in the 1940 Act) of less than 200% (i.e., for every
dollar of preferred shares outstanding, the Fund is required to have at least two dollars of assets).&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The terms of the preferred shares,
including their distribution rate, voting rights, liquidation preference and redemption provisions, will be determined by the Board (subject
to applicable law and the Fund&#x2019;s Declaration of Trust) if and when it authorizes the preferred shares. The Fund may issue preferred
shares that provide for the periodic redetermination of the distribution rate at relatively short intervals through an auction or remarketing
procedure, although the terms of the preferred shares may also enable the Fund to lengthen such intervals. At times, the distribution
rate on the Fund&#x2019;s preferred shares may exceed the Fund&#x2019;s return after expenses on the investment of proceeds from the preferred
shares, resulting in a lower rate of return to Common Shareholders than if the preferred shares were not outstanding.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;i&gt;Preferred Shares. &lt;/i&gt;On May&#160;9,
2012, the Fund issued 464 Series&#160;2015/6-VTN VMTP Shares (the &#x201c;Preferred Shares&#x201d;), with a liquidation preference of $100,000
per share, pursuant to an offering exempt from registration under the Securities Act of 1933, as amended (the &#x201c;1933 Act&#x201d;).
The Preferred Shares are a variable rate form of preferred shares with a mandatory redemption date and are considered debt for financial
reporting purposes. Effective December&#160;1, 2023, the Fund extended the term of the Preferred Shares and is required to redeem all
outstanding Preferred Shares on June&#160;4, 2029, unless earlier redeemed, repurchased or extended. The Preferred Shares are subject
to optional and mandatory redemption in certain circumstances. The redemption price per share is equal to the sum of the liquidation preference
per share plus any accumulated but unpaid dividends and a redemption premium, if any. Starting six months prior to the term redemption
date, the Fund will be required to earmark assets having a value equal to 110% of the redemption amount.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;As of February&#160;28, 2026, the
Fund had outstanding preferred shares with an aggregate liquidation preference of $46,400,000, representing approximately 3.73% of the
Fund&#x2019;s total assets as of such date.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Effects of Leverage&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Assuming (i)&#160;the use by the
Fund of leverage representing approximately 31.67% of the Fund&#x2019;s total assets (including the proceeds of such leverage), 12.42%
of the Fund&#x2019;s total assets being attributable to borrowings and 19.25% of the Fund&#x2019;s total assets being attributable to preferred
shares, and (ii)&#160;interest costs to the Fund at an average annual rate of 3.11%
with respect to borrowings and dividends on preferred shares at an annual rate of 3.73%, then the incremental income generated by the
Fund&#x2019;s portfolio (net of estimated expenses related to the leverage) must exceed approximately 5.69% to cover such interest expense.
Of course, these numbers are merely estimates used for illustration. The amount of leverage used by the Fund as well as actual interest
expenses and dividend payments on such leverage may vary frequently and may be significantly higher or lower than the rate estimated above.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;The
following table is furnished pursuant to requirements of the SEC. It is designed to illustrate the effect of leverage on Common Share
total return, assuming investment portfolio total returns (comprised of income, net expenses and changes in the value of investments held
in the Fund&#x2019;s portfolio) of -10%, -5%, 0%, 5% and 10%. These assumed investment portfolio returns are hypothetical figures and are
not necessarily indicative of what the Fund&#x2019;s investment portfolio returns will be. The table further reflects the issuance of leverage
representing approximately 31.67% of the Fund&#x2019;s total assets (including the proceeds of such leverage), and the Fund&#x2019;s currently
projected annual interest rate of 3.11%
with respect to borrowings and projected annual dividends on preferred shares of 3.73%. The table does not reflect any offering costs
of Common Shares or leverage.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt; 


&lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="width:35%;font:bold 10pt Times New Roman, Times, Serif;text-align:left"&gt;Assumed portfolio total return (net of expenses)&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(10.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(5.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt"&gt;Common Share total return&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(13.14&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(7.29&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(1.44&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4.40&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.25&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;  &lt;/div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Common Share total return is composed of two elements&#x2014;the
Common Share dividends paid by the Fund (the amount of which is largely determined by the Fund&#x2019;s net investment income after paying
the carrying cost of leverage) and realized and unrealized gains or losses on the value of the securities the Fund owns. As required by
SEC rules, the table assumes that the Fund is more likely to suffer capital loss than to enjoy capital appreciation. For example, to assume
a total return of 0%, the Fund must assume that the net investment income it receives on its investments is entirely offset by losses
on the value of those investments. This table reflects the hypothetical performance of the Fund&#x2019;s portfolio and not the performance
of the Fund&#x2019;s Common Shares, the value of which will be determined by market and other factors.&lt;/p&gt; &lt;/div&gt; </cef:EffectsOfLeverageTextBlock>
    <cef:AnnualInterestRatePercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20260612120231519"
      unitRef="Pure">0.0311</cef:AnnualInterestRatePercent>
    <cef:EffectsOfLeveragePurposeTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612120431965">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;The
following table is furnished pursuant to requirements of the SEC. It is designed to illustrate the effect of leverage on Common Share
total return, assuming investment portfolio total returns (comprised of income, net expenses and changes in the value of investments held
in the Fund&#x2019;s portfolio) of -10%, -5%, 0%, 5% and 10%. These assumed investment portfolio returns are hypothetical figures and are
not necessarily indicative of what the Fund&#x2019;s investment portfolio returns will be. The table further reflects the issuance of leverage
representing approximately 31.67% of the Fund&#x2019;s total assets (including the proceeds of such leverage), and the Fund&#x2019;s currently
projected annual interest rate of 3.11%
with respect to borrowings and projected annual dividends on preferred shares of 3.73%. The table does not reflect any offering costs
of Common Shares or leverage.&lt;/span&gt;</cef:EffectsOfLeveragePurposeTextBlock>
    <cef:AnnualInterestRatePercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20260612115958474"
      unitRef="Pure">0.0311</cef:AnnualInterestRatePercent>
    <cef:EffectsOfLeverageTableTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612120538347">


&lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="width:35%;font:bold 10pt Times New Roman, Times, Serif;text-align:left"&gt;Assumed portfolio total return (net of expenses)&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(10.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(5.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;5.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.00&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left;padding-bottom:1pt"&gt;Common Share total return&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(13.14&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(7.29&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(1.44&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4.40&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.25&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </cef:EffectsOfLeverageTableTextBlock>
    <cef:ReturnAtMinusTenPercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20260612120031442"
      unitRef="Pure">-0.1314</cef:ReturnAtMinusTenPercent>
    <cef:ReturnAtMinusFivePercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20260612120043243"
      unitRef="Pure">-0.0729</cef:ReturnAtMinusFivePercent>
    <cef:ReturnAtZeroPercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20260612120048563"
      unitRef="Pure">-0.0144</cef:ReturnAtZeroPercent>
    <cef:ReturnAtPlusFivePercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20260612120206394"
      unitRef="Pure">0.044</cef:ReturnAtPlusFivePercent>
    <cef:ReturnAtPlusTenPercent
      contextRef="C_20260615to20260615"
      decimals="4"
      id="Fxbrl_20260612120210055"
      unitRef="Pure">0.1025</cef:ReturnAtPlusTenPercent>
    <cef:RiskFactorsTableTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612115629487">


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="a_010"&gt;&lt;strong&gt;RISKS&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Risk is inherent in all investing.
Investing in any investment company security involves risk, including the risk that you may receive little or no return on your investment
or even that you may lose part or all of your investment. Please refer to the section of the Fund&#x2019;s most recent &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/883265/000119312526210646/d122322dncsr.htm"&gt;annual
report&lt;/a&gt; on Form&#160;N-CSR entitled &#x201c;Additional Information-Investment Objective, Policies and Principal Risks of the Trust-Principal
Risks of Investing in the Trust,&#x201d; as such principal risks may be supplemented from time to time, which is incorporated by reference
herein, for a discussion of the principal risks you should consider before making an investment in the Fund. Any additional risks applicable
to a particular offering of Securities will be set forth in the related Prospectus Supplement.&lt;/p&gt; &lt;/div&gt; </cef:RiskFactorsTableTextBlock>
    <cef:CapitalStockTableTextBlock
      contextRef="C_20260615to20260615"
      id="Fxbrl_20260612114153304">


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, serif;margin:0pt 0px;text-align:center"&gt;&lt;span id="a_016"&gt;&lt;strong&gt;DESCRIPTION OF CAPITAL STRUCTURE&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund is a statutory trust organized
under the laws of Delaware pursuant to a Certificate of Trust, dated as of April&#160;2, 2012. The following is a brief description of
the terms of the Common Shares, Borrowings and preferred shares which may be issued by the Fund. This description does not purport to
be complete and is qualified by reference to the Fund&#x2019;s Governing Documents.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common
Shares&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Declaration of Trust permits
the Fund to issue an unlimited number of full and fractional common shares of beneficial interest, no par value. Each Common Share represents
an equal proportionate interest in the assets of the Fund with each other Common Share in the Fund. &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Holders
of Common Shares will be entitled to the payment of distributions when, as and if declared by the Board. The 1940 Act or the terms of
any borrowings or preferred shares may limit the payment of distributions to the holders of Common Shares.&lt;/span&gt; &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Each
whole Common Share shall be entitled to one vote as to matters on which it is entitled to vote pursuant to the terms of the Declaration
of Trust on file with the SEC.&lt;/span&gt; &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Upon
liquidation of the Fund, after paying or adequately providing for the payment of all liabilities of the Fund and the liquidation preference
with respect to any outstanding preferred shares, the Trustees may distribute the remaining assets of the Fund among the holders of the
Common Shares on a &lt;i&gt;pro rata &lt;/i&gt;basis.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;While there are any borrowings or
preferred shares outstanding, the Fund may not be permitted to declare any cash distribution on its Common Shares, unless at the time
of such declaration, (i)&#160;all accrued distributions on preferred shares or accrued interest on borrowings have been paid and (ii)&#160;the
value of the Fund&#x2019;s total assets (determined after deducting the amount of such distribution), less all liabilities and indebtedness
of the Fund not represented by senior securities, is at least 300% of the aggregate amount of such securities representing indebtedness
and at least 200% of the aggregate amount of securities representing indebtedness plus the aggregate liquidation value of the outstanding
preferred shares (expected to equal the aggregate original purchase price of the outstanding preferred shares plus the applicable redemption
premium, if any, together with any accrued and unpaid distributions thereon, whether or not earned or declared and on a cumulative basis).
In addition to the requirements of the 1940 Act, the Fund may be required to comply with other asset coverage requirements as a condition
of the Fund obtaining a rating of the preferred shares from a rating agency. These requirements may include an asset coverage test more
stringent than under the 1940 Act. This limitation on the Fund&#x2019;s ability to make distributions on its Common Shares could in certain
circumstances impair the ability of the Fund to maintain its qualification for taxation as a RIC for federal income tax purposes. The
Fund intends, however, to the extent possible to purchase or redeem preferred shares or reduce borrowings from time to time to maintain
compliance with such asset coverage requirements and may pay special distributions to the holders of the preferred shares in certain circumstances
in connection with any such impairment of the Fund&#x2019;s status as a RIC. Depending on the timing of any such redemption or repayment,
the Fund may be required to pay a premium in addition to the liquidation preference of the preferred shares to the holders thereof.&lt;/p&gt;
&lt;/div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;The
Common Shares have no preemptive rights or subscription rights.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in"&gt;The Fund will not issue certificates for the Common Shares.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Issuance of Additional Common Shares&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Any additional offering of Common
Shares will be subject to the requirements of the 1940 Act. The provisions of the 1940 Act generally require that the public offering
price (less underwriting commissions and discounts) of common shares sold by a closed-end investment company must equal or exceed the
net asset value of such company&#x2019;s common shares (calculated within 48 hours of the pricing of such offering), unless such sale is
made with the consent of a majority of its Common Shareholders.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Rights Offerings&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may in the future, and at
its discretion, choose to make offerings of rights to its shareholders to purchase Common Shares. Rights may be issued independently or
together with any other offered security and may or may not be transferable by the person purchasing or receiving the rights. In connection
with a rights offering to shareholders, the Fund would distribute certificates or other documentation (i.e., rights cards distributed
in lieu of certificates) evidencing the rights and a Prospectus Supplement to the Fund&#x2019;s shareholders as of the record date that
the Fund sets for determining the shareholders eligible to receive rights in such rights offering. Any such future rights offering will
be made in accordance with the 1940 Act. Under the laws of Delaware, the Board is authorized to approve rights offerings without obtaining
shareholder approval.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The staff of the SEC has interpreted
the 1940 Act as not requiring shareholder approval of a transferable rights offering to purchase Common Shares at a price below the then
current net asset value so long as certain conditions are met, including: (i)&#160;a good faith determination by a fund&#x2019;s board
that such offering would result in a net benefit to existing shareholders; (ii)&#160;the offering fully protects shareholders&#x2019; preemptive
rights and does not discriminate among shareholders (except for the possible effect of not offering fractional rights); (iii)&#160;management
uses its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights; and
(iv)&#160;the ratio of a transferable rights offering does not exceed one new share for each three rights held.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The applicable Prospectus Supplement
would describe the following terms of the rights in respect of which this Prospectus is being delivered:&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;the period of time the offering would remain open;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the underwriter or distributor, if any, of the rights and any associated underwriting fees or discounts applicable
        to purchases of the rights;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;the title of such rights;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the exercise price for such rights (or method of calculation thereof);&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the number of such rights issued in respect of each Share;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the number of rights required to purchase a single Share;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the extent to which such rights are transferable and the market on which they may be traded if they are transferable;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance
        or exercise of such rights;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;  &lt;/div&gt; 


&lt;div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the date on which the right to exercise such rights will commence, and the date on which such right will expire
        (subject to any extension);&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the extent to which such rights include an over-subscription privilege with respect to unsubscribed securities
        and the terms of such over-subscription privilege; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;termination rights we may have in connection with such rights offering.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;A certain number of rights would entitle the holder
of the right(s)&#160;to purchase for cash such number of Common Shares at such exercise price as in each case is set forth in, or be determinable
as set forth in, the Prospectus Supplement relating to the rights offered thereby. Rights would be exercisable at any time up to the close
of business on the expiration date for such rights set forth in the Prospectus Supplement. After the close of business on the expiration
date, all unexercised rights would become void. Upon expiration of the rights offering and the receipt of payment and the rights certificate
or other appropriate documentation properly executed and completed and duly executed at the corporate trust office of the rights agent,
or any other office indicated in the Prospectus Supplement, the Common Shares purchased as a result of such exercise will be issued as
soon as practicable. To the extent permissible under applicable law, we may determine to offer any unsubscribed offered securities directly
to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth
in the applicable Prospectus Supplement.&lt;/p&gt; &lt;/div&gt; 


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;Repurchase of Common Shares&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Because shares of closed-end funds
frequently trade at a discount to their net asset values, the Board has determined that from time to time it may be in the interest of
holders of Common Shares for the Fund to take corrective actions. The Board, in consultation with the Adviser, will review at least annually
the possibility of open market repurchases and/or tender offers for the Common Shares and will consider such factors as the market price
of the Common Shares, the net asset value of the Common Shares, the liquidity of the assets of the Fund, effect on the Fund&#x2019;s expenses,
whether such transactions would impair the Fund&#x2019;s status as a RIC or result in a failure to comply with applicable asset coverage
requirements, general economic conditions and such other events or conditions which may have a material effect on the Fund&#x2019;s ability
to consummate such transactions. There are no assurances that the Board will, in fact, decide to undertake either of these actions or
if undertaken, that such actions will result in the Fund&#x2019;s Common Shares trading at a price which is equal to or approximates their
net asset value. In recognition of the possibility that the Common Shares might trade at a discount to net asset value and that any such
discount may not be in the interest of holders of Common Shares, the Board, in consultation with the Adviser, from time to time may review
possible actions to reduce any such discount.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Preferred
Shares&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Declaration of Trust authorizes
the issuance of an unlimited number of shares of beneficial interest with preference rights, including preferred shares, no par value,
in one or more series, with rights as determined by the Board, by action of the Board without the approval of the holders of Common Shares.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Under the requirements of the 1940
Act, the Fund must, immediately after the issuance of any preferred shares, have an &#x201c;asset coverage&#x201d; of at least 200%. Asset
coverage means the ratio which the value of the total assets of the Fund, less all liability and indebtedness not represented by senior
securities (as defined in the 1940 Act), bears to the aggregate amount of senior securities representing indebtedness of the Fund, if
any, plus the aggregate liquidation preference of the preferred shares. The liquidation value of the preferred shares is expected to equal
their aggregate original purchase price plus the applicable redemption premium, if any, together with any accrued and unpaid distributions
thereon (on a cumulative basis), whether or not earned or declared. The terms of the preferred shares, including their distribution rate,
voting rights, liquidation preference and redemption provisions, will be determined by the Board (subject to applicable law and the Fund&#x2019;s
Declaration of Trust) if and when it authorizes the preferred shares. The Fund may issue preferred shares that provide for the periodic
redetermination of the distribution rate at relatively short intervals through an auction or remarketing procedure, although the terms
of the preferred shares may also enable the Fund to lengthen such intervals. At times, the distribution rate on the Fund&#x2019;s preferred
shares may exceed the Fund&#x2019;s return after expenses on the investment of proceeds from the preferred shares, resulting in a lower
rate of return to Common Shareholders than if the preferred shares were not outstanding.&lt;/p&gt; &lt;/div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;In
the event of any voluntary or involuntary liquidation, dissolution or winding up of the Fund, the terms of any preferred shares may entitle
the holders of preferred shares to receive a preferential liquidating distribution (expected to equal the original purchase price per
share plus the applicable redemption premium, if any, together with accrued and unpaid distributions, whether or not earned or declared
and on a cumulative basis) before any distribution of assets is made to holders of Common Shares. After payment of the full amount of
the liquidating distribution to which they are entitled, the preferred shareholders would not be entitled to any further participation
in any distribution of assets by the Fund.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Holders
of preferred shares, voting as a class, shall be entitled to elect two of the Fund&#x2019;s Trustees. Under the 1940 Act, if at any time
distributions on the preferred shares are unpaid in an amount equal to two full years&#x2019; distributions thereon, the holders of all
outstanding preferred shares, voting as a class, will be allowed to elect a majority of the Fund&#x2019;s Trustees until all distributions
in arrears have been paid or declared and set apart for payment.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;In addition, if the Board determines
it to be in the best interests of the Common Shareholders, issuance of the preferred shares may result in more restrictive provisions
than required by the 1940 Act being imposed. In this regard, holders of the preferred shares may be entitled to elect a majority of the
Fund&#x2019;s Board in other circumstances, for example, if one payment on the preferred shares is in arrears.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;i&gt;Preferred Shares. &lt;/i&gt;On May&#160;9,
2012, the Fund issued 464 Series&#160;2015/6-VTN VMTP Preferred Shares with a liquidation preference of $100,000 per share, pursuant to
an offering exempt from registration under the 1933 Act. The Preferred Shares are a variable rate form of preferred shares with a mandatory
redemption date and are considered debt for financial reporting purposes. Effective December&#160;1, 2023, the Fund extended the term
of the Preferred Shares and is required to redeem all outstanding Preferred Shares on June&#160;4, 2029, unless earlier redeemed, repurchased
or extended. The Preferred Shares are subject to optional and mandatory redemption in certain circumstances. The redemption price per
share is equal to the sum of the liquidation preference per share plus any accumulated but unpaid dividends and a redemption premium,
if any. Starting six months prior to the term redemption date, the Fund will be required to earmark assets having a value equal to 110%
of the redemption amount.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;Dividends paid on the Preferred Shares
(which are treated as interest expense for financial reporting purposes) are declared daily and paid monthly. The rate for dividends will
be determined in accordance with the procedures included in the Amended and Restated Statement of Preferences of Variable Rate Muni Term
Preferred Shares, as supplemented, for the Preferred Shares. The Fund is subject to certain restrictions relating to the Preferred Shares,
such as maintaining certain asset coverage and leverage ratio requirements. Failure to comply with these restrictions could preclude the
Fund from declaring any distributions to Common Shareholders or purchasing Common Shares and/or could trigger the mandatory redemption
of Preferred Shares at liquidation preference.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Borrowings&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may utilize leverage through
borrowings, including through a credit facility, commercial paper program or other borrowing program. Under the 1940 Act, the Fund is
not permitted to incur indebtedness, including through the issuance of debt securities, unless immediately thereafter the total asset
value of the Fund&#x2019;s portfolio is at least 300% of the liquidation value of the outstanding indebtedness (i.e., such liquidation
value may not exceed 33 1/3% of the Fund&#x2019;s total assets). In addition, the Fund is not permitted to declare any cash distribution
on its Common Shares unless, at the time of such declaration, the net asset value of the Fund&#x2019;s portfolio (determined after deducting
the amount of such distribution) is at least 300% of such liquidation value. If the Fund borrows money, the Fund intends, to the extent
possible, to retire outstanding debt, from time to time, to maintain coverage of any outstanding indebtedness of at least 300%.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may negotiate with commercial
banks to arrange a borrowing facility pursuant to which the Fund may borrow an amount equal to approximately one-third of the Fund&#x2019;s
total assets (inclusive of the amount borrowed). Any such borrowings would constitute leverage. Such a borrowing facility is not expected
to be convertible into any other securities of the Fund, outstanding amounts are expected to be prepayable by the Fund prior to final
maturity without significant penalty and there are not expected to be any sinking fund or mandatory retirement provisions. Outstanding
amounts would be payable at maturity or such earlier times as required by the agreement. The Fund may be required to prepay outstanding
amounts under the borrowing facility or incur a penalty rate of interest upon the occurrence of certain events of default. The Fund would
be expected to indemnify the lenders against liabilities they may incur in connection with the borrowing facility.&lt;/p&gt; &lt;/div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;In addition, the Fund expects that
a borrowing facility would contain covenants that, among other things, likely will limit the Fund&#x2019;s ability to pay distributions
in certain circumstances, incur additional debt, change its fundamental investment policies and engage in certain transactions, including
mergers and consolidations, and may require asset coverage ratios in addition to those required by the 1940 Act. The Fund may be required
to pledge its assets and to maintain a portion of its assets in cash or high-grade securities as a reserve against interest or principal
payments and expenses. The Fund expects that any borrowing facility would have customary covenant, negative covenant and default provisions.
There can be no assurance that the Fund will enter into an agreement for a borrowing facility on terms and conditions representative of
the foregoing, or that additional material terms will not apply. In addition, if entered into, any such borrowing facility may in the
future be replaced or refinanced by one or more borrowing facilities having substantially different terms or by the issuance of preferred
shares or debt securities.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Capitalization&lt;/strong&gt;&lt;/p&gt; 


&lt;div style="font-size:10pt;font-family:Times New Roman"&gt;


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in"&gt;The following table provides information about the outstanding
securities of the Fund as of June&#160;9, 2026:&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="white-space:nowrap;border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;width:61%"&gt;Title of Class&lt;/td&gt;
    &lt;td style="white-space:nowrap;padding-bottom:1pt;width:1%;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space:nowrap;border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;width:12%;text-align:center"&gt;Amount&lt;br/&gt;Authorized&lt;/td&gt;
    &lt;td style="white-space:nowrap;padding-bottom:1pt;width:1%;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space:nowrap;padding-bottom:1pt;width:1%;font:bold 10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space:nowrap;border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;width:10%;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;Amount
        Held by the&lt;br/&gt;Fund or for its&lt;br/&gt;Account&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space:nowrap;padding-bottom:1pt;width:1%;font:bold 10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space:nowrap;padding-bottom:1pt;width:1%;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space:nowrap;border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;width:12%;text-align:center"&gt;Amount&lt;br/&gt;Outstanding&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common
        Shares of Beneficial Interest, no par value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align:center;font:10pt Times New Roman, Times, Serif"&gt;Unlimited&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;--&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align:center;font:10pt Times New Roman, Times, Serif"&gt;14,656,237.17&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Preferred
        Shares of Beneficial Interest, no par value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align:center;font:10pt Times New Roman, Times, Serif"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;464&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;--&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align:center;font:10pt Times New Roman, Times, Serif"&gt;464&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; </cef:CapitalStockTableTextBlock>
    <cef:SecurityTitleTextBlock
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember"
      id="Fxbrl_20260612114220999">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common
Shares&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SecurityDividendsTextBlock
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember"
      id="Fxbrl_20260612114252601">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Holders
of Common Shares will be entitled to the payment of distributions when, as and if declared by the Board. The 1940 Act or the terms of
any borrowings or preferred shares may limit the payment of distributions to the holders of Common Shares.&lt;/span&gt;</cef:SecurityDividendsTextBlock>
    <cef:SecurityVotingRightsTextBlock
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember"
      id="Fxbrl_20260612114317012">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Each
whole Common Share shall be entitled to one vote as to matters on which it is entitled to vote pursuant to the terms of the Declaration
of Trust on file with the SEC.&lt;/span&gt;</cef:SecurityVotingRightsTextBlock>
    <cef:SecurityLiquidationRightsTextBlock
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember"
      id="Fxbrl_20260612114341380">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Upon
liquidation of the Fund, after paying or adequately providing for the payment of all liabilities of the Fund and the liquidation preference
with respect to any outstanding preferred shares, the Trustees may distribute the remaining assets of the Fund among the holders of the
Common Shares on a &lt;i&gt;pro rata &lt;/i&gt;basis.&lt;/span&gt;</cef:SecurityLiquidationRightsTextBlock>
    <cef:SecurityPreemptiveAndOtherRightsTextBlock
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember"
      id="Fxbrl_20260612114511066">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;The
Common Shares have no preemptive rights or subscription rights.&lt;/span&gt;</cef:SecurityPreemptiveAndOtherRightsTextBlock>
    <cef:RightsLimitedByOtherSecuritiesTextBlock
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember"
      id="Fxbrl_20260612114548074">


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Rights Offerings&lt;/strong&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The Fund may in the future, and at
its discretion, choose to make offerings of rights to its shareholders to purchase Common Shares. Rights may be issued independently or
together with any other offered security and may or may not be transferable by the person purchasing or receiving the rights. In connection
with a rights offering to shareholders, the Fund would distribute certificates or other documentation (i.e., rights cards distributed
in lieu of certificates) evidencing the rights and a Prospectus Supplement to the Fund&#x2019;s shareholders as of the record date that
the Fund sets for determining the shareholders eligible to receive rights in such rights offering. Any such future rights offering will
be made in accordance with the 1940 Act. Under the laws of Delaware, the Board is authorized to approve rights offerings without obtaining
shareholder approval.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The staff of the SEC has interpreted
the 1940 Act as not requiring shareholder approval of a transferable rights offering to purchase Common Shares at a price below the then
current net asset value so long as certain conditions are met, including: (i)&#160;a good faith determination by a fund&#x2019;s board
that such offering would result in a net benefit to existing shareholders; (ii)&#160;the offering fully protects shareholders&#x2019; preemptive
rights and does not discriminate among shareholders (except for the possible effect of not offering fractional rights); (iii)&#160;management
uses its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights; and
(iv)&#160;the ratio of a transferable rights offering does not exceed one new share for each three rights held.&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;The applicable Prospectus Supplement
would describe the following terms of the rights in respect of which this Prospectus is being delivered:&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;the period of time the offering would remain open;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the underwriter or distributor, if any, of the rights and any associated underwriting fees or discounts applicable
        to purchases of the rights;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;the title of such rights;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the exercise price for such rights (or method of calculation thereof);&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the number of such rights issued in respect of each Share;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the number of rights required to purchase a single Share;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the extent to which such rights are transferable and the market on which they may be traded if they are transferable;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance
        or exercise of such rights;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; 


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the date on which the right to exercise such rights will commence, and the date on which such right will expire
        (subject to any extension);&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;the extent to which such rights include an over-subscription privilege with respect to unsubscribed securities
        and the terms of such over-subscription privilege; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="width:100%;font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:0.5in"&gt;&lt;/td&gt;
    &lt;td style="width:0.25in"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align:justify"&gt;termination rights we may have in connection with such rights offering.&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;A certain number of rights would entitle the holder
of the right(s)&#160;to purchase for cash such number of Common Shares at such exercise price as in each case is set forth in, or be determinable
as set forth in, the Prospectus Supplement relating to the rights offered thereby. Rights would be exercisable at any time up to the close
of business on the expiration date for such rights set forth in the Prospectus Supplement. After the close of business on the expiration
date, all unexercised rights would become void. Upon expiration of the rights offering and the receipt of payment and the rights certificate
or other appropriate documentation properly executed and completed and duly executed at the corporate trust office of the rights agent,
or any other office indicated in the Prospectus Supplement, the Common Shares purchased as a result of such exercise will be issued as
soon as practicable. To the extent permissible under applicable law, we may determine to offer any unsubscribed offered securities directly
to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth
in the applicable Prospectus Supplement.&lt;/p&gt; &lt;/div&gt; </cef:RightsLimitedByOtherSecuritiesTextBlock>
    <cef:SecurityTitleTextBlock
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265PreferredSharesMember"
      id="Fxbrl_20260612114652210">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Preferred
Shares&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SecurityLiquidationRightsTextBlock
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265PreferredSharesMember"
      id="Fxbrl_20260612114913297">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;In
the event of any voluntary or involuntary liquidation, dissolution or winding up of the Fund, the terms of any preferred shares may entitle
the holders of preferred shares to receive a preferential liquidating distribution (expected to equal the original purchase price per
share plus the applicable redemption premium, if any, together with accrued and unpaid distributions, whether or not earned or declared
and on a cumulative basis) before any distribution of assets is made to holders of Common Shares. After payment of the full amount of
the liquidating distribution to which they are entitled, the preferred shareholders would not be entitled to any further participation
in any distribution of assets by the Fund.&lt;/span&gt;</cef:SecurityLiquidationRightsTextBlock>
    <cef:SecurityVotingRightsTextBlock
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265PreferredSharesMember"
      id="Fxbrl_20260612115043865">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Holders
of preferred shares, voting as a class, shall be entitled to elect two of the Fund&#x2019;s Trustees. Under the 1940 Act, if at any time
distributions on the preferred shares are unpaid in an amount equal to two full years&#x2019; distributions thereon, the holders of all
outstanding preferred shares, voting as a class, will be allowed to elect a majority of the Fund&#x2019;s Trustees until all distributions
in arrears have been paid or declared and set apart for payment.&lt;/span&gt;</cef:SecurityVotingRightsTextBlock>
    <cef:OutstandingSecuritiesTableTextBlock
      contextRef="C_20260609to20260609"
      id="Fxbrl_20260612154642373">


&lt;div style="font-size:10pt;font-family:Times New Roman"&gt;


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.5in"&gt;The following table provides information about the outstanding
securities of the Fund as of June&#160;9, 2026:&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="white-space:nowrap;border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;width:61%"&gt;Title of Class&lt;/td&gt;
    &lt;td style="white-space:nowrap;padding-bottom:1pt;width:1%;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space:nowrap;border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;width:12%;text-align:center"&gt;Amount&lt;br/&gt;Authorized&lt;/td&gt;
    &lt;td style="white-space:nowrap;padding-bottom:1pt;width:1%;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space:nowrap;padding-bottom:1pt;width:1%;font:bold 10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space:nowrap;border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;width:10%;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;Amount
        Held by the&lt;br/&gt;Fund or for its&lt;br/&gt;Account&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space:nowrap;padding-bottom:1pt;width:1%;font:bold 10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space:nowrap;padding-bottom:1pt;width:1%;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space:nowrap;border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;width:12%;text-align:center"&gt;Amount&lt;br/&gt;Outstanding&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common
        Shares of Beneficial Interest, no par value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align:center;font:10pt Times New Roman, Times, Serif"&gt;Unlimited&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;--&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align:center;font:10pt Times New Roman, Times, Serif"&gt;14,656,237.17&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Preferred
        Shares of Beneficial Interest, no par value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align:center;font:10pt Times New Roman, Times, Serif"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;464&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;--&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align:center;font:10pt Times New Roman, Times, Serif"&gt;464&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20260609to20260609_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember"
      id="Fxbrl_20260612115205430">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common
        Shares of Beneficial Interest, no par value&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20260609to20260609_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember"
      decimals="0"
      id="Fxbrl_20260612115308387"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265CommonSharesMember"
      decimals="INF"
      id="Fxbrl_20260612162844613"
      unitRef="SHARES">14656237.17</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20260609to20260609_usgaapStatementClassOfStockAxis_ck0000883265PreferredSharesMember"
      id="Fxbrl_20260612115218650">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Preferred
        Shares of Beneficial Interest, no par value&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20260609to20260609_usgaapStatementClassOfStockAxis_ck0000883265PreferredSharesMember"
      decimals="0"
      id="Fxbrl_20260612115318475"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20260615to20260615_usgaapStatementClassOfStockAxis_ck0000883265PreferredSharesMember"
      decimals="INF"
      id="Fxbrl_20260612162855125"
      unitRef="SHARES">464</cef:OutstandingSecurityNotHeldShares>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20250911101706440"
          xlink:label="Fxbrl_20250911101706440"
          xlink:type="locator"/>
        <link:footnote id="FN20260612132242909" xlink:label="FN20260612132242909" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">If Common Shares to which this Prospectus relates are sold to or through underwriters, the Prospectus Supplement will set forth any applicable sales charge and the estimated offering expenses borne by the Fund</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911101706440"
          xlink:to="FN20260612132242909"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911101757511"
          xlink:label="Fxbrl_20250911101757511"
          xlink:type="locator"/>
        <link:footnote id="FN20260612132258880" xlink:label="FN20260612132258880" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common Shareholders will pay service fee of $[2.50] and brokerage charges if they direct the Plan Agent to sell Common Shares held in a dividend reinvestment account. See &#x201c;Dividend Reinvestment Plan.&#x201d;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911101757511"
          xlink:to="FN20260612132258880"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911101943998"
          xlink:label="Fxbrl_20250911101943998"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911101943998"
          xlink:to="FN20260612132258880"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911102016265"
          xlink:label="Fxbrl_20250911102016265"
          xlink:type="locator"/>
        <link:footnote id="FN20260612132329923" xlink:label="FN20260612132329923" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Based upon average net assets applicable to Common Shares for the annual period ended February 28, 2026.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911102016265"
          xlink:to="FN20260612132329923"
          xlink:type="arc"/>
        <link:footnote id="FN20260612132405372" xlink:label="FN20260612132405372" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund pays the Adviser an annual fee, payable monthly, in an amount equal to 0.55% of the Fund&#x2019;s average daily Managed Assets. The fee shown above is based upon outstanding leverage of 31.67% of the Fund&#x2019;s total assets. If leverage of more than 31.67% of the Fund&#x2019;s total assets is used, the management fees shown would be higher.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911102016265"
          xlink:to="FN20260612132405372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911102110609"
          xlink:label="Fxbrl_20250911102110609"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911102110609"
          xlink:to="FN20260612132329923"
          xlink:type="arc"/>
        <link:footnote id="FN20260612132419637" xlink:label="FN20260612132419637" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Based upon the Fund&#x2019;s outstanding borrowings as of February 28, 2026 of approximately $29,945,000, and outstanding preferred shares as of February 28, 2026 of approximately 46,400,000, and the average daily weighted interest rate for the period ended February 28, 2026 of 3.11%, and dividends on preferred shares at an annual rate of 3.73%.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911102110609"
          xlink:to="FN20260612132419637"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911102201673"
          xlink:label="Fxbrl_20250911102201673"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911102201673"
          xlink:to="FN20260612132329923"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911102338481"
          xlink:label="Fxbrl_20250911102338481"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911102338481"
          xlink:to="FN20260612132329923"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911133232245"
          xlink:label="Fxbrl_20250911133232245"
          xlink:type="locator"/>
        <link:footnote id="FN20260612143410075" xlink:label="FN20260612143410075" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The example above does not include sales charges or estimated offering costs. In connection with an offering of Common Shares, the Prospectus Supplement will set forth an Example including sales charge and estimated offering costs.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911133232245"
          xlink:to="FN20260612143410075"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911133228998"
          xlink:label="Fxbrl_20250911133228998"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911133228998"
          xlink:to="FN20260612143410075"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911102735890"
          xlink:label="Fxbrl_20250911102735890"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911102735890"
          xlink:to="FN20260612143410075"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911102706139"
          xlink:label="Fxbrl_20250911102706139"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911102706139"
          xlink:to="FN20260612143410075"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161929690"
          xlink:label="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161929690"
          xlink:type="locator"/>
        <link:footnote id="FN20260612132732773" xlink:label="FN20260612132732773" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Calculated by subtracting the Fund&#x2019;s total liabilities (not including preferred shares, at liquidation value) from the Fund&#x2019;s total assets and dividing this by the total number of preferred shares outstanding.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161929690"
          xlink:to="FN20260612132732773"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161927890"
          xlink:label="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161927890"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161927890"
          xlink:to="FN20260612132732773"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161925986"
          xlink:label="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161925986"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161925986"
          xlink:to="FN20260612132732773"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161922482"
          xlink:label="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161922482"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161922482"
          xlink:to="FN20260612132732773"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161920858"
          xlink:label="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161920858"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911162843802_xbrl_20250911162343107_xbrl_20250911161920858"
          xlink:to="FN20260612132732773"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022236487_xbrl_20250911112302270"
          xlink:label="Fxbrl_20260612022236487_xbrl_20250911112302270"
          xlink:type="locator"/>
        <link:footnote id="FN20260612132957554" xlink:label="FN20260612132957554" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Calculated based on the information presented. Percentages are rounded.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022236487_xbrl_20250911112302270"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022236487_xbrl_20250911112234615"
          xlink:label="Fxbrl_20260612022236487_xbrl_20250911112234615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022236487_xbrl_20250911112234615"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022236487_xbrl_20250911112216274"
          xlink:label="Fxbrl_20260612022236487_xbrl_20250911112216274"
          xlink:type="locator"/>
        <link:footnote id="FN20260612132857078" xlink:label="FN20260612132857078" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Based on the Fund&#x2019;s computations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022236487_xbrl_20250911112216274"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022236487_xbrl_20250911112156844"
          xlink:label="Fxbrl_20260612022236487_xbrl_20250911112156844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022236487_xbrl_20250911112156844"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022235119_xbrl_20250911112302270"
          xlink:label="Fxbrl_20260612022235119_xbrl_20250911112302270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022235119_xbrl_20250911112302270"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022235119_xbrl_20250911112234615"
          xlink:label="Fxbrl_20260612022235119_xbrl_20250911112234615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022235119_xbrl_20250911112234615"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022235119_xbrl_20250911112216274"
          xlink:label="Fxbrl_20260612022235119_xbrl_20250911112216274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022235119_xbrl_20250911112216274"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022235119_xbrl_20250911112156844"
          xlink:label="Fxbrl_20260612022235119_xbrl_20250911112156844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022235119_xbrl_20250911112156844"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022233881_xbrl_20250911112302270"
          xlink:label="Fxbrl_20260612022233881_xbrl_20250911112302270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022233881_xbrl_20250911112302270"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022233881_xbrl_20250911112234615"
          xlink:label="Fxbrl_20260612022233881_xbrl_20250911112234615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022233881_xbrl_20250911112234615"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022233881_xbrl_20250911112216274"
          xlink:label="Fxbrl_20260612022233881_xbrl_20250911112216274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022233881_xbrl_20250911112216274"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260612022233881_xbrl_20250911112156844"
          xlink:label="Fxbrl_20260612022233881_xbrl_20250911112156844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260612022233881_xbrl_20250911112156844"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112302270"
          xlink:label="Fxbrl_20250911112302270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112302270"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112234615"
          xlink:label="Fxbrl_20250911112234615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112234615"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112216274"
          xlink:label="Fxbrl_20250911112216274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112216274"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112156844"
          xlink:label="Fxbrl_20250911112156844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112156844"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112452223_xbrl_20250911112302270"
          xlink:label="Fxbrl_20250911112452223_xbrl_20250911112302270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112452223_xbrl_20250911112302270"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112452223_xbrl_20250911112234615"
          xlink:label="Fxbrl_20250911112452223_xbrl_20250911112234615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112452223_xbrl_20250911112234615"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112452223_xbrl_20250911112216274"
          xlink:label="Fxbrl_20250911112452223_xbrl_20250911112216274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112452223_xbrl_20250911112216274"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112452223_xbrl_20250911112156844"
          xlink:label="Fxbrl_20250911112452223_xbrl_20250911112156844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112452223_xbrl_20250911112156844"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112453826_xbrl_20250911112302270"
          xlink:label="Fxbrl_20250911112453826_xbrl_20250911112302270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112453826_xbrl_20250911112302270"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112453826_xbrl_20250911112234615"
          xlink:label="Fxbrl_20250911112453826_xbrl_20250911112234615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112453826_xbrl_20250911112234615"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112453826_xbrl_20250911112216274"
          xlink:label="Fxbrl_20250911112453826_xbrl_20250911112216274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112453826_xbrl_20250911112216274"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112453826_xbrl_20250911112156844"
          xlink:label="Fxbrl_20250911112453826_xbrl_20250911112156844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112453826_xbrl_20250911112156844"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112455356_xbrl_20250911112302270"
          xlink:label="Fxbrl_20250911112455356_xbrl_20250911112302270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112455356_xbrl_20250911112302270"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112455356_xbrl_20250911112234615"
          xlink:label="Fxbrl_20250911112455356_xbrl_20250911112234615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112455356_xbrl_20250911112234615"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112455356_xbrl_20250911112216274"
          xlink:label="Fxbrl_20250911112455356_xbrl_20250911112216274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112455356_xbrl_20250911112216274"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112455356_xbrl_20250911112156844"
          xlink:label="Fxbrl_20250911112455356_xbrl_20250911112156844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112455356_xbrl_20250911112156844"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112457369_xbrl_20250911112302270"
          xlink:label="Fxbrl_20250911112457369_xbrl_20250911112302270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112457369_xbrl_20250911112302270"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112457369_xbrl_20250911112234615"
          xlink:label="Fxbrl_20250911112457369_xbrl_20250911112234615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112457369_xbrl_20250911112234615"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112457369_xbrl_20250911112216274"
          xlink:label="Fxbrl_20250911112457369_xbrl_20250911112216274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112457369_xbrl_20250911112216274"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112457369_xbrl_20250911112156844"
          xlink:label="Fxbrl_20250911112457369_xbrl_20250911112156844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112457369_xbrl_20250911112156844"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112459390_xbrl_20250911112302270"
          xlink:label="Fxbrl_20250911112459390_xbrl_20250911112302270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112459390_xbrl_20250911112302270"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112459390_xbrl_20250911112234615"
          xlink:label="Fxbrl_20250911112459390_xbrl_20250911112234615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112459390_xbrl_20250911112234615"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112459390_xbrl_20250911112216274"
          xlink:label="Fxbrl_20250911112459390_xbrl_20250911112216274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112459390_xbrl_20250911112216274"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112459390_xbrl_20250911112156844"
          xlink:label="Fxbrl_20250911112459390_xbrl_20250911112156844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112459390_xbrl_20250911112156844"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112501141_xbrl_20250911112302270"
          xlink:label="Fxbrl_20250911112501141_xbrl_20250911112302270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112501141_xbrl_20250911112302270"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112501141_xbrl_20250911112234615"
          xlink:label="Fxbrl_20250911112501141_xbrl_20250911112234615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112501141_xbrl_20250911112234615"
          xlink:to="FN20260612132957554"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112501141_xbrl_20250911112216274"
          xlink:label="Fxbrl_20250911112501141_xbrl_20250911112216274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112501141_xbrl_20250911112216274"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250911112501141_xbrl_20250911112156844"
          xlink:label="Fxbrl_20250911112501141_xbrl_20250911112156844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250911112501141_xbrl_20250911112156844"
          xlink:to="FN20260612132857078"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
